Up next

Autoplay

Cefiderocol vs High-Dose Meropenem for the Treatment of Patients With Nosocomial Pneumonia

0 Views • 08/24/25
Share
Side Effects
Side Effects
Subscribers
0

Ryan K. Shields, PharmD, MS, reacts to research presented at IDWeek 2019 on cefiderocol versus high-dose meropenem for patients with nosocomial pneumonia.

Show more
0 Comments sort Sort By

Up next

Autoplay